{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:42:03Z","timestamp":1769730123290,"version":"3.49.0"},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1248\/bpb.b19-00367","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T22:03:53Z","timestamp":1567289033000},"page":"1562-1568","source":"Crossref","is-referenced-by-count":10,"title":["Diurnal Variation of Sitagliptin-Induced Pharmacological Effects in C57BL\/6J Mice"],"prefix":"10.1248","volume":"42","author":[{"given":"Hiroki","family":"Yoshioka","sequence":"first","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Hirose","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rurika","family":"Ohishi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tominaga","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Torii-Goto","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jun","family":"Park","sequence":"additional","affiliation":[{"name":"College of Human and Environment, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Miura","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental and Molecular Toxicology, Department of Health Science, Yokohoma University of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kinjo Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. <i>Lancet<\/i>, <b>373<\/b>, 1773\u20131779 (2009)."},{"key":"2","unstructured":"2) Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. <i>Obes. Rev.<\/i>, <b>5<\/b> (Suppl. 1), 4\u201385 (2004)."},{"key":"3","unstructured":"3) Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes? <i>Diabetes Metab. Syndr. Obes.<\/i>, <b>7<\/b>, 241\u2013253 (2014)."},{"key":"4","unstructured":"4) Majumdar SK, Inzucchi SE. Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy? <i>Endocrine<\/i>, <b>44<\/b>, 47\u201358 (2013)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Scheen AJ. Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes. <i>Expert Opin. Drug Saf.<\/i>, <b>14<\/b>, 505\u2013524 (2015).","DOI":"10.1517\/14740338.2015.1006625"},{"key":"6","unstructured":"6) Zerilli T, Pyon EY. Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. <i>Clin. Ther.<\/i>, <b>29<\/b>, 2614\u20132634 (2007)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. <i>J. Clin. Invest.<\/i>, <b>121<\/b>, 2133\u20132141 (2011).","DOI":"10.1172\/JCI46043"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. <i>Sleep Med.<\/i>, <b>8<\/b>, 668\u2013680 (2007).","DOI":"10.1016\/j.sleep.2006.11.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Delfino RJ, Zeiger RS, Seltzer JM, Street DH, Matteucci RM, Anderson PR, Koutrakis P. The effect of outdoor fungal spore concentrations on daily asthma severity. <i>Environ. Health Perspect.<\/i>, <b>105<\/b>, 622\u2013635 (1997).","DOI":"10.1289\/ehp.97105622"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. <i>Circulation<\/i>, <b>75<\/b>, 395\u2013400 (1987).","DOI":"10.1161\/01.CIR.75.2.395"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Beauchamp D, Labrecque G. Chronobiology and chronotoxicology of antibiotics and aminoglycosides. <i>Adv. Drug Deliv. Rev.<\/i>, <b>59<\/b>, 896\u2013903 (2007).","DOI":"10.1016\/j.addr.2006.07.028"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Huang XL, Fu CJ, Bu RF. Role of circadian clocks in the development and therapeutics of cancer. <i>J. Int. Med. Res.<\/i>, <b>39<\/b>, 2061\u20132066 (2011).","DOI":"10.1177\/147323001103900601"},{"key":"13","unstructured":"13) Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). <i>J. Pediatr. Endocrinol. Metab.<\/i>, <b>12<\/b> (Suppl. 3), 751\u2013758 (1999)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Henriksson E, Huber AL, Soto EK, Kriebs A, Vaughan ME, Duglan D, Chan AB, Papp SJ, Nguyen M, Afetian ME, Lamia KA. The liver circadian clock modulates biochemical and physiological responses to metformin. <i>J. Biol. Rhythms<\/i>, <b>32<\/b>, 345\u2013358 (2017).","DOI":"10.1177\/0748730417710348"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yoshioka H, Mizuno Y, Yamaguchi T, Ichimaru Y, Takeya K, Hitotsuyanagi Y, Nonogaki T, Aoyagi Y. Methyl dehydroabietate counters high fat diet-induced insulin resistance and hepatic steatosis by modulating peroxisome proliferator-activated receptor signaling in mice. <i>Biomed. Pharmacother.<\/i>, <b>99<\/b>, 214\u2013219 (2018).","DOI":"10.1016\/j.biopha.2018.01.064"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yoshioka H, Nonogaki T, Fukuishi N, Shinohara Y, Hwang GW, Ohtani K, Miura N. Chronotoxicity of bromobenzene-induced hepatic injury in mice. <i>J. Toxicol. Sci.<\/i>, <b>42<\/b>, 251\u2013258 (2017).","DOI":"10.2131\/jts.42.251"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK, Kim JG, Lee IK, Kim MK, Park KG. Sitagliptin attenuates methionine\/choline-deficient diet-induced steatohepatitis. <i>Diabetes Res. Clin. Pract.<\/i>, <b>105<\/b>, 47\u201357 (2014).","DOI":"10.1016\/j.diabres.2014.04.028"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. <i>Trends Cell Biol.<\/i>, <b>17<\/b>, 311\u2013317 (2007).","DOI":"10.1016\/j.tcb.2007.07.001"},{"key":"19","unstructured":"19) Lemmer B. Chronopharmacology and its impact on antihypertensive treatment. <i>Acta Physiol. Pharmacol. Bulg.<\/i>, <b>24<\/b>, 71\u201380 (1999)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Dobrian AD, Ma Q, Lindsay JW, Leone KA, Ma K, Coben J, Galkina EV, Nadler JL. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. <i>Am. J. Physiol. Endocrinol. Metab.<\/i>, <b>300<\/b>, E410\u2013E421 (2011).","DOI":"10.1152\/ajpendo.00463.2010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Omar BA, Vikman J, Winzell MS, Voss U, Ekblad E, Foley JE, Ahren B. Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. <i>Diabetologia<\/i>, <b>56<\/b>, 1752\u20131760 (2013).","DOI":"10.1007\/s00125-013-2927-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Wang ZY, Tobin EM. Constitutive expression of the CIRCADIAN CLOCK ASSOCIATED 1 (CCA1) gene disrupts circadian rhythms and suppresses its own expression. <i>Cell<\/i>, <b>93<\/b>, 1207\u20131217 (1998).","DOI":"10.1016\/S0092-8674(00)81464-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. <i>Science<\/i>, <b>308<\/b>, 1043\u20131045 (2005).","DOI":"10.1126\/science.1108750"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. <i>PLOS Biol.<\/i>, <b>2<\/b>, e377 (2004).","DOI":"10.1371\/journal.pbio.0020377"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. <i>Genes Dev.<\/i>, <b>20<\/b>, 1868\u20131873 (2006).","DOI":"10.1101\/gad.1432206"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, Turek FW, Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. <i>Cell Metab.<\/i>, <b>6<\/b>, 414\u2013421 (2007).","DOI":"10.1016\/j.cmet.2007.09.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ando H, Takamura T, Matsuzawa-Nagata N, Shima KR, Eto T, Misu H, Shiramoto M, Tsuru T, Irie S, Fujimura A, Kaneko S. Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. <i>Diabetologia<\/i>, <b>52<\/b>, 329\u2013335 (2009).","DOI":"10.1007\/s00125-008-1194-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Paschos GK, Baggs JE, Hogenesch JB, FitzGerald GA. The role of clock genes in pharmacology. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>50<\/b>, 187\u2013214 (2010).","DOI":"10.1146\/annurev.pharmtox.010909.105621"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lyseng-Williamson KA. Sitagliptin. <i>Drugs<\/i>, <b>67<\/b>, 587\u2013597 (2007).","DOI":"10.2165\/00003495-200767040-00007"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/9\/42_b19-00367\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T03:21:24Z","timestamp":1567826484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/9\/42_b19-00367\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00367","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}